Peg-L-Asparaginase

Peg-L-Asparaginase is a chemotherapy medication used to treat certain types of leukemia, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). It works by depleting the body’s supply of asparagine, an amino acid essential for cancer cell growth.

Uses: Peg-L-Asparaginase is primarily used to treat:

• Acute lymphoblastic leukemia (ALL)
• Acute myeloid leukemia (AML)

Important Considerations (Prescription Required):

1. Severe Side Effects: Peg-L-Asparaginase can cause severe side effects, including blood clotting problems, allergic reactions, and liver damage. It is crucial to consult with a healthcare professional before starting treatment.
2. Prescription Only: Peg-L-Asparaginase is a prescription medication and should only be used under the guidance of a qualified medical professional.
3. Regular Monitoring: During treatment, regular monitoring is necessary to assess for side effects and adjust the dosage as needed.